Abstract Characterization of the genetic landscape of Alzheimer’s disease (AD) and related
dementias (ADD) provides a unique opportunity for a better understanding of the associated …

Current criteria for the clinical diagnosis of pathologically confirmed corticobasal
degeneration (CBD) no longer reflect the expanding understanding of this disease and its …

Microglia maintain homeostasis in the brain, but whether aberrant microglial activation can
cause neurodegeneration remains controversial. Here, we use transcriptome profiling to …

Progressive supranuclear palsy (PSP) is a movement disorder with prominent tau neuropathology.
Brain diseases with abnormal tau deposits are called tauopathies, the most common …

Background Frontotemporal dementia is a highly heritable neurodegenerative disorder. In
about a third of patients, the disease is caused by autosomal dominant genetic mutations …

Objective To report clinical and laboratory characteristics, treatment, and clinical outcomes
of patients admitted for neurologic diseases with and without coronavirus disease 2019 (…

We assessed the geographical distribution of C9orf72 G 4 C 2 expansions in a pan‐ E
uropean frontotemporal lobar degeneration ( FTLD ) cohort (n = 1,205), ascertained by the E …

Objectives: To investigate whether the combination of fluoro-2-deoxy-d-glucose (FDG) PET
measures with the APOE genotype would improve prediction of the conversion from mild …

Relating clinical symptoms to neuroanatomical profiles of brain damage and ultimately to
tissue pathology is a key challenge in the field of neurodegenerative disease and particularly …

Background Frontotemporal dementia (FTD) is a complex disorder characterised by a broad
range of clinical manifestations, differential pathological signatures, and genetic variability. …